4/A: Perrigo Director Amends Share Purchase Filing

Perrigo Company plc Director Geoffrey M. Parker amended a Form 4 filing to correct the reported ownership type of 4,375 shares acquired on August 18, 2025.

Summary

• Geoffrey M. Parker, a Director of Perrigo Company plc (PRGO), filed an amended Form 4 on August 19, 2025.
• The amendment corrects details regarding the acquisition of 4,375 Ordinary Shares on August 18, 2025, at a price of $22.9708 per share.
• The original Form 4, filed on August 19, 2025, incorrectly reported these shares as acquired directly by Mr. Parker.
• The corrected filing clarifies that the 4,375 shares were acquired indirectly by the Geoffrey M. Parker Roth IRA.
• Following this transaction, Mr. Parker's indirect beneficial ownership through the Roth IRA totals 9,875 Ordinary Shares.
• Other beneficial ownership includes 28,912 Ordinary Shares held directly and 25,879 Ordinary Shares held indirectly via a revocable trust.

Sentiment

Score: 6

Explanation: The filing is an administrative amendment to a previously reported insider transaction. The underlying transaction, an insider share purchase, is generally viewed as a positive signal of confidence, though the amendment itself is a neutral administrative correction.

Positives

• An insider, Director Geoffrey M. Parker, acquired 4,375 Ordinary Shares, which can signal confidence in the company's future prospects.
• The acquisition was made at a specific price of $22.9708 per share.

Related Party Transactions

• Acquisition of 4,375 Ordinary Shares by Geoffrey M. Parker Roth IRA, an entity related to Director Geoffrey M. Parker.
• Beneficial ownership of 25,879 Ordinary Shares held indirectly through a revocable trust where Geoffrey Parker and Jill Parker are trustees.

Stakeholder Impact

• Shareholders may view the insider purchase as a positive signal of management confidence. The correction ensures accurate public record of ownership.

Key Dates

Recommendation

The filing is an administrative amendment to a previously reported insider share purchase. While insider buying can be a positive signal, this specific filing primarily corrects a detail about the ownership structure rather than revealing new material information. It does not provide sufficient new data to warrant a change in investment thesis, thus a 'hold' recommendation is appropriate.

Keywords

Perrigo, PRGO, SEC Form 4/A, Insider Trading, Share Acquisition, Director, Beneficial Ownership, Roth IRA, Pharmaceuticals, Consumer Healthcare